amikacin has been researched along with Adverse Drug Event in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alder, J; Bassetti, M; Boateng, F; Cao, B; Chastre, J; Corkery, K; Dhand, R; Kaye, KS; Lawatscheck, R; McLeroth, P; Nicolau, DP; Niederman, MS; Wang, C; Wood, GC; Wunderink, RG | 1 |
| De Ponti, F; Faldella, G; Galletti, S; Girardi, A; Koci, A; Poluzzi, E; Raschi, E | 1 |
| Heath, PT; Kent, A; Sharland, M; Turner, MA | 1 |
| Asci, H; Bayram, D; Candan, IA; Cankara, FN; Ilhan, I; Saygin, M; Yesilot, S | 1 |
| Brown, NM; Jenkins, A; Lovering, AM; MacGowan, A; Semple, Y; Sluman, C; Thomson, AH; Wiffen, PJ | 1 |
| Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M | 1 |
| Dequin, PF; Ehrmann, S; Mercier, E; Paintaud, G; Ternant, D; Vecellio, L | 1 |
| Baka, M; Gombakis, N; Kafetzis, DA; Koliouskas, DE; Kosmidou, H; Malaka-Zafiriou, E; Maltezou, HC | 1 |
| Abd El Salam, ASG; Abd Elrazik, NA; Samaha, MM | 1 |
2 review(s) available for amikacin and Adverse Drug Event
| Article | Year |
|---|---|
Aminoglycoside toxicity in neonates: something to worry about?
Topics: Amikacin; Aminoglycosides; Animals; Anti-Infective Agents; Drug-Related Side Effects and Adverse Reactions; Ear, Inner; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Kidney | 2014 |
Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Interrupted Time Series Analysis; Treatment Outcome | 2016 |
3 trial(s) available for amikacin and Adverse Drug Event
| Article | Year |
|---|---|
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
Topics: Administration, Inhalation; Administration, Intravenous; Adult; Aged; Amikacin; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Gram-Negative Bacterial Infections; Hospitals; Humans; Male; Middle Aged; Placebos; Pneumonia, Ventilator-Associated; Prospective Studies; Standard of Care; Survival Analysis; Treatment Outcome; Young Adult | 2020 |
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects.
Topics: Administration, Inhalation; Adult; Aerosols; Amikacin; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; In Vitro Techniques; Infusions, Intravenous; Male | 2008 |
Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Fever; Gentamicins; Humans; Male; Neoplasms; Neutropenia; Random Allocation | 2001 |
7 other study(ies) available for amikacin and Adverse Drug Event
| Article | Year |
|---|---|
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit.
Topics: Amikacin; Ampicillin; Cohort Studies; Critical Care; Drug Therapy, Combination; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Italy; Length of Stay; Male; Pharmaceutical Preparations; Retrospective Studies; Risk Assessment; Treatment Outcome | 2017 |
The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Female; Kidney; Kidney Function Tests; Malondialdehyde; Rats; Rats, Wistar; Renal Insufficiency; Thioctic Acid; Treatment Outcome | 2015 |
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin | 2011 |
Cytoprotective effects of cinnamaldehyde and adipoRon against cyclophosphamide-induced cardio-renal toxicity in rats: Insights into oxidative stress, inflammation, and apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Cyclophosphamide; Drug-Related Side Effects and Adverse Reactions; Inflammation; Kidney; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2023 |